Two to six companies, their latest annual figures side by side, from SEC filings.
| Figure | TXG10x Genomics, Inc.FY2025 · Dec |
|---|---|
| Revenue | $642.82M |
| Revenue, yoy | +5.2% |
| Net income | $43.54M |
| Net income, yoy | +76.2% |
| Net margin | -6.8% |
| Free cash flow | $130.12M |
| FCF margin | 20.2% |
| EPS, diluted | $0.35 |
Add another company.